“ú–{–òŠw‰ï ‘æ136”N‰ïi‰¡•lj@2016”N3ŒŽ26“ú(“y)E27“ú(“ú)E28“ú(ŒŽ)E29“ú(‰Î)@–k—¢‘åŠw–òŠw•” Œö‰vŽÐ’c–@l “ú–{–òŠw‰ï Œö‰vŽÐ’c–@l “ú–{–òŠw‰ï Œö‰vŽÐ’c–@l “ú–{–òŠw‰ï FAQ

3ŒŽ27“ú(æ—¥)@9:00~11:30@B‰ïê パシフィコ横浜 会議センター 3F 301
S01
日本学術会議薬学委員会医療系薬学分科会ä¼ç”»
薬学研究ã®ã“ã‚Œã‹ã‚‰ã€€â€•åŸºç¤Žã¨è‡¨åºŠã®æž¶ã‘橋―
Pharmaceutical Sciences in the Future: The Linking Bridge between Basic and Clinical Research
オーガナイザー:橋田  å……ã€æœ›æœˆ 眞弓

S01-1
基調講演
Keynote lecture
ƒVƒ“ƒ|ƒWƒXƒg F â—‹æ‰å±± 雄一

S01-2
レギュラトリーサイエンスã®è¦–点ã‹ã‚‰
From the viewpoint of regulatory science
ƒVƒ“ƒ|ƒWƒXƒg F ○長野 哲雄

S01-3
医療ç¾å ´ã®è¦–点ã‹ã‚‰ï¼šãƒªãƒãƒ¼ã‚¹ãƒˆãƒ©ãƒ³ã‚¹ãƒ¬ãƒ¼ã‚·ãƒ§ãƒŠãƒ«ãƒªã‚µãƒ¼ãƒã¨ã—ã¦ã®è–¬å‰¤ç–«å­¦
From a view point of clinical settings: pharmacoepidemiology as a reverse translational research (rTR)
ƒVƒ“ƒ|ƒWƒXƒg F â—‹å·ä¸Š 純一

S01-4
標的絶対定é‡çš„プロテオミクスã«åŸºã¥ãPharmacoproteomics:国際共åŒç ”究ã®é‡è¦æ€§
Quantitative targeted absolute proteomics (QTAP) based pharmacoproteomics: Importance of international collaboration
ƒVƒ“ƒ|ƒWƒXƒg F ○寺崎 哲也

S01-5
In silico研究ã®è¦–点ã‹ã‚‰
From the viewpoint of in silico research
ƒVƒ“ƒ|ƒWƒXƒg F ○奥野 æ­å²

S01-6
薬物代è¬ç ”究ã®è¦–点ã‹ã‚‰
From the viewpoint of drug metabolism research
ƒVƒ“ƒ|ƒWƒXƒg F ○中島 美紀

ŒŸõƒy[ƒW‚É–ß‚é

TOP‚Ö–ß‚é
ƒvƒ‰ƒCƒoƒV[ƒ|ƒŠƒV[‚ɂ‚¢‚Ä
@Copyright (C) Œö‰vŽÐ’c–@l“ú–{–òŠw‰ï